Related Experiment Video
Updated: Aug 10, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
Role of the JAK/STAT signaling pathway in diabetic nephropathy
Mario B Marrero1, Amy K Banes-Berceli, David M Stern
1Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA. mmarrero@mail.mcg.edu
Abstract:
Excessive cellular growth is a major contributor to pathological changes associated with diabetic nephropathy. In particular, high glucose-induced growth of glomerular mesangial cells is a characteristic feature of diabetes-induced renal complications. Glomerular mesangial cells respond to traditional growth factors, although in diabetes this occurs in the context of an environment enriched in both circulating vasoactive mediators and high glucose. For example, the vasoactive peptide ANG II has been implicated in the pathogenesis of diabetic renal disease, and recent findings suggest that high glucose and ANG II activate intracellular signaling processes, including the polyol pathway and generation of reactive oxygen species. These pathways activate the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling cascades in glomerular mesangial cells. Activation of the JAK/STAT signaling cascade can stimulate excessive proliferation and growth of glomerular mesangial cells, contributing to diabetic nephropathy. This review focuses on some of the key elements in the diabetic microenvironment, especially high glucose and the accumulation of advanced glycoxidation end products and considers their impact on ANG II and other vasoactive peptide-mediated signaling events in vitro and in vivo.
Related Concept Videos
The JAK-STAT Signaling Pathway
Diabetic Nephropathy
PI3K/mTOR/AKT Signaling Pathway
Type II Diabetes II: Pathophysiology
Amplifying Signals via Enzymatic Cascade
Type I Diabetes II: Pathophysiology